BioSpace News Archive

St. Croix Hospice, a Midwest leader in hospice care, announces its innovative new InTouch Family Connection Program.

Today, Orbis is pleased to announce Mary Jane Jamar as the organization’s first-ever Chief Human Resources Officer (CHRO).

VivaLNK, a leading provider of connected healthcare solutions known for its unique medical wearable sensor platform and vitals data service, announces today that Jennifer Esposito joins its Board of Directors.

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that it has entered into a license agreement with Clev

New Advancements to Inpatient Solution Decrease Excess Days, Reduce Burden on Frontline Teams and Create Capacity for Covid-19 and Beyond

Elevar Therapeutics, Inc. (“Elevar”), a fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options, and Tanner Pharma Group (“Tanner”), a global provider of integrated specialty access solutions

Crossover Health, a virtual-first, national medical group, today announced that Chief Executive Officer and Co-Founder, Scott Shreeve, M.D., will give a company update and participate in the “Primary Care v2.0" panel on December 3, 2020 at 12:00 p.m. Eastern.

Menarini Ricerche, the R&D division of the Menarini Group, reported today the positive results of the pharmacodynamic assay demonstrating target engagement in the dose escalation part of the DIAMOND-01 trial (CLI24-001; clinicaltrials.gov identifier NCT03008187), a study investigating SEL24/MEN1703,

Medical Technology Disruptors Panel includes Renovia’s leva® Digital Therapeutic, a novel approach for an underreported disorder affecting 20 million women in the U.S.

SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative global pharmaceutical company focused on developing treatments for central nervous system (CNS) disorders, will present the latest data on its anti-seizure medication (ASM) cenobamate at the American Epilepsy Society AES2020 Virtual Event,